Fujifilm unveils systems integration business

Fujifilm announced it will be launching a systems integration business for...Read more on AuntMinnie.comRelated Reading: Report: Fujifilm makes pitch for Curium Pharma Hitachi board votes to sell medical division to Fujifilm Report: Fujifilm plans to buy Hitachi imaging business Fujifilm to debut glass-free DR panel at RSNA 2019 Fujifilm debuts breast cancer awareness campaign
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Most women who are notified by mail that they have a high risk of breast cancer are unlikely to do anything about it, a small study suggests.Reuters Health Information
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news
Conclusions: Reconstructive practices in a modern cohort of plastic surgeons suggest that immediate and implant reconstructions are performed preferentially. Respondents perceived a number of factors, including surgeon training, time spent in the operating room, and insurance reimbursement, to negatively influence the performance of autologous reconstruction.
Source: Plastic and Reconstructive Surgery - Category: Cosmetic Surgery Tags: Breast: Original Articles Source Type: research
Conclusion: Patients with moderate to severe breast ptosis and/or macromastia who wish to undergo mastectomy with reconstruction can be offered nipple-sparing approaches safely if a staged algorithm is implemented. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
Source: Plastic and Reconstructive Surgery - Category: Cosmetic Surgery Tags: Breast: Original Articles Source Type: research
The male reproductive hormone androgen may hold the key to a new treatment approach for estrogen receptor-positive breast cancer, the most common form of the disease, a new study has found.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
Condition:   Lymphedema, Breast Cancer Intervention:   Procedure: LYMPHA(LYmphatic Microsurgical Preventive Healing Approach) technique Sponsor:   Pusan National University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Diagnostic Test: Serum Autotaxin;   Radiation: chest x-ray;   Diagnostic Test: Breast ultrasound or mammography;   Diagnostic Test: Histopathological examination of breast mass specimens;   Radiation: Magnetic Resonance Imaging ( MRI) and Bone scan;   Diagnostic Test: Peripheral  haemogram;   Diagnostic Test: Renal and liver functions;   Diagnostic Test: Prothrombin time and concentration;   Diagnostic Test: Cancer Antigen...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
As the COVID-19 outbreak worsens in the U.S., at-home test kits for the virus have been a source of both hope and controversy. Their appeal is clear: sick individuals could get a diagnosis from the comfort of home, without infecting others. But their downsides are real: the U.S. Food and Drug Administration (FDA) has cracked down on unauthorized at-home COVID-19 tests, updating its emergency use authorization guidelines to exclude at-home test kits and warning Americans that no such tests have received agency authorization. That means startups previously offering these products—such as Everlywell, Nurx and Carbon Hea...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
There is an urgent need to share expertise and offer emergency guidance for breast radiation therapy (RT) during the COVID-19 (Coronavirus) pandemic. As per the World Health Organisation (WHO) statement, our aim and obligation should be “to stop, contain, control, delay and reduce the impact of this virus at every opportunity”. In our roles as healthcare professionals and/or breast cancer experts this translates to minimising exposure of our patients to COVID-19 without compromising oncological outcome.
Source: Clinical Oncology - Category: Radiology Authors: Tags: Editorial Source Type: research
Research reveals half of radiologists saw no change in their recall rates.
Source: Diagnostic Imaging - Category: Radiology Authors: Tags: Breast Cancer Breast Imaging Mammography Tomosynthesis Source Type: news
(The Endocrine Society) Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments. They will present the results of their new preclinical study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Pharmaceuticals | Radiology